|
Clinical and Demographic features of the Sample |
|||||||
| ASD+ |
ASD- |
ADHD |
TD |
Group effect |
Post hoc Scheffé |
||
| (n = 20) |
(n = 20) |
(n = 20) |
(n = 20) |
F |
p |
||
|
|
|||||||
| No. (%) |
|||||||
|
|
|||||||
| Gender |
2.4 |
0.8 |
|||||
| -male |
19 (94.7) |
16 (80.0) |
19 (95.0) |
14 (70.0) |
|||
| -female |
1 (5.3) |
4 (20.0) |
1 (5.0) |
6 (30.0) |
|||
| Autism diagnosis |
0 |
1.0 |
|||||
| - Asperger syndrome |
15 (75.0) |
15 (75.0) |
- |
- |
|||
| - High-functioning autism |
5 (25.0) |
5 (25.0) |
|||||
| ADHD subtype |
2.0 |
0.2 |
|||||
| - Combined s. |
7 (35.0) |
- |
8 (40.0) |
- |
|||
| - Inattentive only s. |
11 (55.0) |
11 (55.0) |
|||||
| -Hyperactive/Impulsive s. |
2 (10.0) |
1 (5.0) |
|||||
| Comorbid ODD |
9 (45.0) |
6 (30.0) |
11 (55.0) |
- |
1.3 |
0.3 |
|
|
|
|||||||
| Mean (SD) |
|||||||
|
|
|||||||
| Age at testing (years) |
10.9 (3.1) |
14.3 (3.0) |
12.2 (2.0) |
13.1 (3.0) |
4.4 |
0.1 |
ASD+ < ASD-** |
| (6.0–17.0) |
(8.3–18.9) |
(7.1–17.6) |
(7.6–17.6) |
||||
| IQ |
103 (13.0) |
112 (17.7) |
98(13.4) |
113 (11.9) |
5.7 |
0.01 |
ADHD < TD**, ASD-** |
| Min-Max |
(80–131) |
(82–146) |
(80–128) |
(95–144) |
|||
|
*Post hoc Test p < .05; **Post hoc Test p .01; ***Post hoc Test p < .001 Note: ADHD = attention-deficit/hyperactivity disorder; TD = typically developing group; CD = conduct disorder; ODD = oppositional defiant disorder. | |||||||
Sinzig et al. Child and Adolescent Psychiatry and Mental Health 2008 2:4 doi:10.1186/1753-2000-2-4 |
|||||||